- 2026-12-05
-
Efficacy of combination therapy with PARP inhibitors and immune checkpoint inhibitors in recurrent ovarian cancer: a systematic review and meta-analysis
07:49-07:56
Room 502
Mini Oral
Speaker

Yahya Nurlianto
Efficacy of combination therapy with PARP inhibitors and immune checkpoint inhibitors in recurrent ovarian cancer: a systematic review and meta-analysis
07:49-07:56
Room 502
Mini Oral
Speaker